March 11, 2024 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today's roundup of stocks to watch ...
Psychennex Pty Ltd, a subsidiary of Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has commenced preparations of an investigational new drug (‘IND’) application to the U.S.
Qantas is up more than 1.2 per cent mid-session after announcing a $2.47 billion profit for the year to June 30 - its first full-year profit since the onset of COVID-19.
Incannex Healthcare (ASX:IHL) is charging ahead with another US application for an investigational new drug (IND) through its subsidiary psychedelic company, Psychennex.
ASX Futures suggest the market is likely to open higher this morning, following the NASDAQ's best day since July 28, and with US economic data boosting hopes for another pause in federal rate rises.
Biotechnology company Living Cell Technologies (ASX: LCT) is preparing to take the next step in a major makeover with a proposal to be put to shareholders to change its name to Algorae Pharmaceuticals.